Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Hevea brasiliensis latex allergen proteins are a group of over 15 identified proteins found in the milky sap of the Para rubber tree, which are responsible for inducing Type I hypersensitivity reactions in humans (UniProt, 2024). The most clinically significant components include Hev b 1 (Small Rubber Particle Protein) and Hev b 3 (Rubber Elongation Factor), which are essential for the biosynthesis and stabilization of natural rubber particles within the plant (PubMed, PMID: 11851220). In sensitized individuals, exposure to these proteins can lead to symptoms ranging from localized contact urticaria to life-threatening systemic anaphylaxis (World Allergy Organization, 2023). While not traditional targets for small-molecule inhibition, these proteins serve as the primary targets for allergen-specific immunotherapy (ASIT) and are used in standardized extracts for diagnostic skin testing (FDA, 2023). ASIT aims to induce immunological tolerance by modulating T-cell responses and promoting the production of blocking IgG4 antibodies. Additionally, these proteins are the molecular basis for latex-fruit syndrome, where cross-reactivity occurs with homologous proteins in foods such as bananas, avocados, and kiwis (Journal of Allergy and Clinical Immunology, 2021).
Allergen-specific immunotherapy (ASIT) using Hevea brasiliensis extracts works by inducing peripheral T-cell tolerance, increasing the production of regulatory T cells (Tregs), and shifting the antibody response from IgE to IgG4, thereby preventing mast cell degranulation upon subsequent allergen exposure (PubMed, PMID: 21663660).
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Hevea brasiliensis latex allergen proteins (Hev b).